Form D — Antlia Bioscience, Inc.
0001829522-26-000003 · filed Jun 5, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $20,000,000
- Total sold
- $6,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Antlia Bioscience, Inc.
- CIK
- 1829522
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1281 HYMETTUS AVE
ENCINITAS, CA 92024 - Phone
- 619-990-0290
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ankit Mahadevia · Executive OfficerEncinitas, CA Find on LinkedIn ↗
-
Ben Auspitz · DirectorEncinitas, CA Find on LinkedIn ↗
-
Brian Laurence Johnson · Executive OfficerEncinitas, CA Find on LinkedIn ↗
-
Carlos Garcia Echeverria · DirectorEncinitas, CA Find on LinkedIn ↗
-
Nihal Sinha · DirectorEncinitas, CA Find on LinkedIn ↗
-
Martin Taylor · DirectorEncinitas, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗